1. Home
  2. KD vs DYN Comparison

KD vs DYN Comparison

Compare KD & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kyndryl Holdings Inc.

KD

Kyndryl Holdings Inc.

HOLD

Current Price

$13.17

Market Cap

2.8B

Sector

Technology

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$14.78

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KD
DYN
Founded
2020
1984
Country
United States
United States
Employees
80000
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.5B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
KD
DYN
Price
$13.17
$14.78
Analyst Decision
Buy
Strong Buy
Analyst Count
5
16
Target Price
$35.25
$38.63
AVG Volume (30 Days)
9.3M
1.6M
Earning Date
05-11-2026
06-03-2026
Dividend Yield
N/A
N/A
EPS Growth
170.95
N/A
EPS
0.77
N/A
Revenue
$15,057,000,000.00
N/A
Revenue This Year
$3.96
N/A
Revenue Next Year
$0.41
N/A
P/E Ratio
$17.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.10
$7.01
52 Week High
$43.74
$25.00

Technical Indicators

Market Signals
Indicator
KD
DYN
Relative Strength Index (RSI) 37.42 39.60
Support Level $11.34 $14.67
Resistance Level $13.93 $15.23
Average True Range (ATR) 0.62 0.92
MACD 0.56 0.01
Stochastic Oscillator 70.46 33.33

Price Performance

Historical Comparison
KD
DYN

About KD Kyndryl Holdings Inc.

Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: